Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for lung neoplasms.

Steven M Albelda1, Rainer Wiewrodt, Daniel H Sterman

  • 1Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania, USA. Albelda@mail.med.upenn.edu

Clinics in Chest Medicine
|March 21, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The role of pulsed electric field therapy in non-small cell lung cancer: a narrative review of a novel minimally invasive intervention.

Journal of thoracic disease·2026
Same author

Defining the abscopal effect in non-small cell lung cancer in the era of immunotherapy and lung ablation treatment: a narrative review.

Frontiers in medicine·2026
Same author

Tumor draining lymph nodes in non-small cell lung cancer: <i>underrecognized role in biomarker discovery and therapeutic innovation</i>.

Frontiers in immunology·2026
Same author

The role of bronchoscopic cryoimmunotherapy in non-small cell lung cancer: current evidence and future perspectives.

Immunotherapy·2026
Same author

Targeted Lipid Nanoparticle Delivery of FAP-CAR mRNA Enables Potent In Vivo T-cell Engineering against Pancreatic Tumors.

Cancer immunology research·2026
Same author

Phase 1 study of autologous T cells bearing fully human chimeric antigen receptors targeting mesothelin in mesothelin-expressing cancers.

Molecular therapy : the journal of the American Society of Gene Therapy·2026
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Gene therapy shows promise for treating diseases like hemophilia and cancer. Ongoing research focuses on improving vector technology for more effective gene delivery in thoracic malignancies.

Area of Science:

  • Oncology
  • Genetics
  • Biotechnology

Background:

  • Gene therapy, while nascent, has demonstrated successful gene transfer in animal and human studies.
  • Early gene therapy trials for thoracic malignancies, particularly lung cancer and mesothelioma, have provided valuable insights.

Purpose of the Study:

  • To review the initial applications of gene therapy vectors in thoracic cancers.
  • To identify challenges and lessons learned from early-phase clinical trials.
  • To highlight the future direction of gene therapy research in oncology.

Main Methods:

  • Review of Phase 1 gene therapy trials for thoracic malignancies.
  • Analysis of vector delivery efficiency and transgene expression in vivo.
  • Assessment of preliminary efficacy signals in localized and advanced cancers.

Related Experiment Videos

Main Results:

  • Established safety and feasibility of gene transfer in clinical settings.
  • Identified limitations in transgene delivery efficiency and duration.
  • Observed potential therapeutic hints at higher vector doses in localized disease.

Conclusions:

  • Gene therapy is poised to become a significant treatment modality for thoracic malignancies.
  • Advancements in vector technology are crucial for overcoming current delivery challenges.
  • Further research and development are essential for realizing the full therapeutic potential of gene therapy.